Silver has been incorporated into a variety of wound dressings and topical agents to prevent and 12 combat wound infections. Pseudomonas aeruginosa is a common cause of burn wound 13 infections and well-known biofilm producer. The objective of this study was to evaluate the 14 effects of a panel of wound dressings containing different silver formulations on P. aeruginosa 15 biofilms using an in vivo porcine burn wound model. Second-degree burns were created on the 16 skin of specific pathogen-free pigs (n = 3) and inoculated with 2.14 × 10 5 cfu P. aeruginosa per 17 wound. Biofilms were allowed to develop for 24 h, and then each wound was treated with one of 18 6 treatments: silver oxynitrate dressing (OXY), silver oxynitrate powder (POWD), 19 nanocrystalline silver dressing (NANO), silver chloride dressing (AGCL), silver sulfadiazine 20 (SSD), or a negative control polyurethane film with no silver-based formulation (NEG). 21
Introduction 36
Burn wounds feature a compromised skin barrier that can no longer prevent bacteria from 37 reaching deeper tissues. Burns are especially predisposed to infection due the presence of 38 devitalized tissue and hospital stays that can last for months (Black and Costerton, 2001; 39 Brusselaers et al., 2010; Issler-Fisher et al., 2016) . Pseudomonas aeruginosa is one species of 40 bacteria commonly isolated from infected burn wounds and is also present in intensive care burn 41 units which often have higher drug resistance rates than P. aeruginosa isolated from other wards, 42 even within the same hospital (Yali et al., 2014; Issler-Fisher et al., 2016) . P. aeruginosa has 43 been reported to be a leading cause of sepsis and death in burn victims (Davis et al., 2008; 44 Brusselaers et al., 2010; Issler-Fisher et al., 2016) . Infections with P. aeruginosa are of serious 45 concern because this bacterium rapidly produces biofilms, or communities of bacterial cells 46 firmly adhered to a surface and surrounded by an extracellular matrix (Donlan, 2002) . Biofilms are difficult to disrupt within wound tissue, in part because biofilms confer increased tolerance to 48 antimicrobial therapy (Black and Costerton, 2001 ; Davis et al., 2008) . Moreover, biofilms can 49 form very quickly; one strain of P. aeruginosa isolated from a burn wound produced biofilms in 50 vitro within 10 hours (Harrison-Balestra et al., 2003) . Therefore, the ideal antimicrobial 51 treatments for burn wounds would have the ability disrupt biofilm produced by pathogenic 52 bacteria. 53
A survey regarding burn dressings and treatments was sent to healthcare workers from 54 around the world and 84% of respondents believed antimicrobial activity is important in a burn 55 dressing (Selig et al, 2012 ). This antimicrobial activity will ideally not come from systemic 56 antibiotics, as P. aeruginosa is commonly resistant to multiple antibiotics (Potron et al., 2015; 57 Chatterjee et al., 2016) and these drugs must be used prudently to reduce the spread of resistance. 58
Silver is an alternative option to traditional antimicrobials and silver sulfadiazine has been a 59 standard topical treatment for P. aeruginosa in burn patients for several decades (Fox, 1968 ; 60 Barillo and Marx, 2014) . In some cases, silver sulfadiazine has been shown to impair the wound 61 healing process (Davis et al., 1990; Mertz et al., 1996; Rosen et al., 2015) , thus alternate topical 62 antimicrobial options are still needed. Silver-releasing compounds other than SSD have become 63 popular in wound dressings over the past few decades, and antimicrobial efficacy is often 64 dependent on the formulation of silver used and the delivery mechanism (Meyer et al., 1978; 65 Sullivan et al., 2001) . Silver can be coated directly on fibers within wound dressings or can be 66 incorporated into creams that are applied onto burn wounds. Ionic silver in the form of Ag + is 67 essential for antimicrobial activity and is the most common bioactive silver currently available in 68 a wide range of dressing formats. More recently, the novel silver formulation silver oxynitate, 69 that releases the higher oxidation state silver ions Ag 2+ and Ag 3+ , is hypothesized to have greater 70 bactericidal activity than Ag + because of the higher affinity for electrons, subsequently leading to 71 greater microbial cellular damage (Lemire et al., 2015; Kalan et al., 2017) . 72
The objective of this study was to compare the in vivo antimicrobial activity of different 73 silver-formulations incorporated into commercial wound dressings against biofilms of P. 74 aeruginosa within porcine burn wounds. 75
Materials & Methods 76
Experimental Animals 77
The experimental animal protocol used for this study was approved by the University of 78 Miami Institutional Animal Care and Use Committee, and all procedures followed the federal 79 guidelines for the care and use of laboratory animals (U.S. Department of Health and Human 80 Services, U.S. Department of Agriculture). The studies were conducted in compliance with the 81
University of Miami's Department of Dermatology and Cutaneous Surgery Standard Operating 82
Procedure. Animals were monitored daily for any signs of pain or discomfort. To minimize 83 possible discomfort, animals were given analgesics throughout the study. 84
Three animals were used for this study. The young female specific pathogen free (Looper 85 Farms, North Carolina) pigs weighing 40-45 kg were kept in-house for at least 5 days prior to 86 initiating the experiment. The animals were fed a basal diet ad libitum and housed individually in 87
American Association for Accreditation of Laboratory Animal accredited animal facilities with a 88 controlled temperature of 19-21 o C a photoperiod of 12 h light and 12 h dark. 89
Wounding 90
For the wounding process, animals were anesthetized, and the paravertebral area of 91 experimental animals were shaved with standard animal clippers. The area was prepared for 92 wounding by washing with a non-antibiotic soap (Neutrogena Soap Bar; Johnson & Johnson, 93 Los Angeles, CA) and sterile water. The skin was then blotted dry with sterile gauze. 94
Fifty-four second degree burn wounds were made on each animal using 5 specially 95 designed cylindrical brass rods weighing 358 g each that were heated in a boiling water bath to 96 100°C. A brass rod was removed from the water bath, wiped dry to prevent water droplets from 97 creating a steam burn on the skin, and applied to the skin surface. The rod was held vertically on 98 the skin for 6 seconds, with all pressure supplied by gravity, to make a burn wound 8.5 mm 99 across and 0.8 mm deep. Immediately after burning, the roof of the burn blister was removed 100 with a sterile spatula. Wounds were separated from one another by 6-8 cm of unwounded skin. 101
The day of wounding is D0. 102
Wound Inoculation 103
Pseudomonas aeruginosa ATCC 27312, which was originally isolated from a human wound, 104 was used in this study. The challenge inoculum suspension was prepared by scraping overnight 105 growth from a culture plate into 4.5 mL normal saline. This resulted in a suspension concentration of 106 approximately 10 10 cfu/mL. Serial dilutions were made until a final estimated concentration of 10 6 107 cfu/mL was achieved. The final suspension was vortexed and 25 μL was inoculated into each burn 108 wound on D0, the same day the burns were created. All wounds were covered with a polyurethane 109 film dressing (Tegaderm, 3M, St. Paul, MN) within 30 min of inoculation and the dressing was kept 110 in place for 24 h to allow for biofilm formation (Harrison-Balestra et al., 2003). Serial dilutions of the 111 inoculum were plated onto culture media to quantify the viable organisms used for the experiment. 112
Treatments 113
After 24 hours (D1), the polyurethane dressings were removed. Three wounds per treatment 114 per animal were tested for baseline bacterial counts as described in the "Recovery Methods" 115 below. The remaining wounds were randomly assigned to one of six treatment groups: Silver 116
Oxynitrate Dressing (KerraContact Ag) dressing containing silver oxynitrate at 0.4 mg/cm 2 117 (OXY; Crawford Healthcare, Doylestown, PA), 150 mg pure silver oxynitrate powder (POWD;  118 Exciton Technologies, Edmonton, AB), 350 mg silver sulfadiazine (SSD; positive control, 119
Watson Laboratories), Nanocrystalline silver dressing (ACTICOAT 7) containing 120 nanocrystalline silver at 1.2-1.4 mg/cm 2 (NANO; Smith & Nephew, Austin, TX), and a dressing 121 containing AgCl, EDTA, and benzalkonium chloride (AQUACEL Ag EXTRA; AGCL; 122 ConvaTec, Greensboro, NC). For a negative control wounds were treated with polyurethane film 123 dressing only (NEG; negative control). Six wounds per animal were treated with OXY, NANO, 124 or AGCL. Nine wounds per animal were treated with POWD, SSD, or NEG to permit 125 histological analysis. 126
Each wound was dressed with 5 cm × 5 cm piece of dressing that covered the wounded area 127 and surrounding unwounded skin. Dressings were applied according to the manufacturers' 128 instructions and dressed wounds from all treatment groups were covered with the NEG 129 polyurethane film dressing to prevent cross contamination. OXY was wet with 200 µL sterile 130 water, which was added on top and then absorbed into the dressing with a sterile spatula. Both 131 POWD and SSD were spread evenly onto the wound with sterile spatulas. NANO was wet with 132 1000 µL sterile water as per the manufacturer's directions to activate the dressing properties. 133 AGCL was more absorbent than other treatments and was therefore wet with 4000 µL sterile 134 water. The NEG wounds received no treatment other than the polyurethane film. All wounds 135 were treated on D1, 24 hours after P. aeruginosa challenge, and treatments were reapplied on 136 D3, 48 hours after initial treatment application, for final bacterial recovery on D6 with the 137 exception of SSD. SSD was applied every 24 hours as per the manufacturer's instructions. 138
Bacterial Recovery 139
Three wounds prior to treatment were cultured on D1 to establish the baseline bacterial 140 load within wound. Three wounds per animal per treatment group were recovered on D3 and 3 141 wounds per animal per treatment were recovered on D6. A sterile surgical steel cylinder with a 142 22-mm inside diameter was placed around the wound area and 1 mL neutralizer solution was 143 pipetted into the cylinder. The site was scrubbed with a sterile spatula for 30 s and the neutralizer 144 suspension was then serially diluted and plated with the Spiral Plater System (Spiral Biotech, 145
Norwood, MA). The suspension was plated on Pseudomonas agar base with cetrimide-nalidixic 146 acid supplement to isolate P. aeruginosa. Colonies were counted after 24 h aerobic incubation at 147
37°C. 148
Histology 149
Three biopsies from each pig were taken from treatments OXY, SSD, and NEG on D6 150 for histological analysis. Incisional biopsies were obtained through the center of the wounds 151 including normal adjacent skin on both sides. Biopsies were fixed in formalin, stained with 152 hematoxylin and eosin, and sectioned. One section per biopsy was evaluated with light 153 microscopy by a researcher who was blinded to the treatments. Sections were examined for the 154 following elements: 155 1.
Wound epithelialization: the percentage of the wound surface that had been covered 156 with new epithelium. 157
2.
Epithelial thickness: the thickness of the new epithelium within the wound. 158
3.
White cell infiltrate: the amount of subepithelial mixed leukocytic infiltrates. Score: 159 1 = absent, 2 = mild, 3 = moderate, 4 = marked, 5 = exuberant. Figure 3A ). Treatment group was strongly associated with bacterial recovery at both D3 (P < 183 0.0001) and D6 (P < 0.0001) ( Figure 3A ). However, there was a strong interaction of treatment × 184 time (P < 0.0001), as different treatment groups resulted in different reductions in bacterial counts at the two timepoints ( Figure 3B ). The POWD treatment group had the greatest bacterial 186 reduction as compared to NEG on both days, with a reduction in P. aeruginosa counts of 7.17 187 log on D3 (P < 0.0001) and 6.85 log on D6 (P < 0.0001). The POWD-treated wounds also had 188 significantly reduced bacterial recovery compared to every other silver formulation on both days 189 (P < 0.0001). Bacterial recovery from POWD was below the limit of quantification (LOQ) on 190 D3 and D6 ( Figure 3A) . On D3, the P. aeruginosa yields were similar from OXY, positive 191 control SSD, and NANO, with 2.36, 3.03, and 2.62 log reductions in bacterial recovery 192 compared to the NEG, respectively (P < 0.0001; Figure 3B ). AGCL caused a reduction in 193 bacterial recovery at D3 of approximately 1.01 log compared to the NEG at D3 (P < 0.0001; 194 Figure 3B ) but did not decrease recovery as compared to the baseline (P = 0.91). 195
On D6, the NEG-treated wounds had a log bacterial recovery of 9.15±0.47 cfu/mL. The 196 positive control SSD, OXY, and NANO maintained significant bacterial reductions from D3 197 compared to the negative control on D6 (P < 0.0001). The log reductions compared to the 198 negative control were 2.90, 3.92, and 3.89 for treatments SSD, OXY, and NANO, respectively. 199
The AGCL treatment resulted in a 0.90-log reduction in bacterial recovery relative to the NEG 200 (P = 0.001) at D6 ( Figure 3B ) but were not significantly different from the baseline bacterial 201 recovery (P < 0.34). 202
Wound appearance 203
All wounds had slight erythema prior to treatment and this erythema was no longer 204 present by D3. A representative dressed wound from each treatment on D3 after the removal of 205 the polyurethane film is presented in Figure 2A -F. Dressings remained in place for all treatments 206 until being removed by research personnel except for AGCL, which was partially displaced from 207 3 wounds. The AGCL dressing was slightly adherent to the wound bed during the dressing 208 removal process, one wound from the OXY group had slight adherence to the dressing on D6, 209 and all other treatments were easily removed without adherence to the wound. 210
Histology 211
Three wounds per animal were subject to biopsy and examined histologically at D6 for 3 212 treatment groups: OXY, SSD, and NEG. The mean epithelialization of the wounds at D6 was 213 87% ( Figure 4A ) and mean epithelial thickness was 85 μ m ( Figure 4B ). White cell infiltration 214 was moderate in the 3 treatment groups ( Figure 4C ) and granulation tissue formation was 215 generally between 11-30% ( Figure 4D ). Angiogenesis was mild (score 2) for each biopsy, 216 regardless of treatment. None of the 5 histological measures differed among treatment groups. 217
Discussion 218
The ideal burn treatment would maintain a moist environment and pH, manage exudate, 219 and prevent infection, all without disturbing the healing process of the burned tissue or causing 220 pain to the patient (Selig et al, 2012) . Nearly all respondents to a survey of medical professionals 221 who deal with burn wounds believed that such a dressing does not exist (Selig et al, 2012) . The United States Food and Drug Administration (FDA) requires a bacterial reduction of 245 at least 4-log (99.99%) by a wound dressing as compared to a negative control treatment for the 246 dressing to be considered antimicrobial (FDA, 2009). Although each silver formulation we tested 247 resulted in a reduced bacterial recovery as compared to the negative control after three and six 248 days of infection, only the silver oxynitrate powder resulted in a log reduction value to fulfill the 249 FDA's 4-log requirement on both D3 and D6. Even the positive control silver sulfadiazine, 250 which has been in use in burn patients since the 1960s (Barillo and Marx, 2014), only decreased 251 P. aeruginosa counts by 3.03 log (99.91%). The AGCL dressing is marketed as an anti-biofilm 252 dressing, however in our study we did not observe significant log reduction of biofilm from burn 253 wounds. While there was a reduction compared to the untreated negative control of ~1 log, we 254 observed no change from the baseline in bacterial counts. This suggests AGCL may suppress 255 further proliferation of P. aeruginosa in the tissue, but may only have modest antimicrobial 256 activity against already existing biofilm. Of the traditional contact layer dressings, the OXY and 257 NANO dressings did reached a 4-log level of reduction by D6. The OXY dressing is coated with 258 silver oxynitrate at a concentration of 0.4 mg/cm 2 resulting in an effective exposure of ~10 mg 259 per dressing in this study. The POWD treatment was administered at a concentration of 150 mg 260 per wound to evaluate potential toxicity at a high dose. Our results suggest that silver oxynitrate 261 is effective at disrupting P. aeruginosa biofilms at much lower dose but even at high doses is not 262
toxic. 263
Burn dressings should have antimicrobial activity without impairing the wound healing 264 process. Silver sulfadiazine's impairment of wound healing is a well-documented drawback of 265 the treatment (Poon and Burd, 2004; Rosen et al., 2015) , and we performed histological analysis 266 for a preliminary comparison of treatments on the wound healing process. Compared to the NEG 267 or SSD, POWD dramatically reduced the number of viable P. aeruginosa within the burn 268 wounds without noticeably affecting the speed of the wound healing process. In a recent study, 269 the higher-oxidation state silver released by OXY and POWD resulted in uninfected wounds in 270 mice to close more quickly than wounds that were not treated with silver (Thomason et al, 2018) , 271 but the contractile nature of wound closure in mice may translates less directly into human 272 wound closure than the porcine model used in the current study. Detection of differences in 273 wound healing metrics such as epithelialization rate and white cell infiltration would require a 274 greater sample size and longer follow-up time than we were able to utilize. Additionally, the in 275 vivo activity of the most effective treatment we used here, the POWD, should be tested in 276 additional burn wound pathogens as silver oxysalts have been demonstrated to have in vitro 277 antimicrobial activity against a spectrum of bacteria that includes multi-drug resistant 278
Acinetobacter baumannii, Staphylococcus aureus, and Enterococcus faecalis (Kalan et al., 279 2017) . 280
Conclusions 281
Pseudomonas aeruginosa was able to colonize burn wounds on porcine skin and silver-282 containing treatments reduced bacterial counts in wounds at 2-and 5-days post-infection. Silver 283 oxynitrate powder had the greatest reduction in P. aeruginosa biofiom and we were unable to 284 detect changes in wound healing progress compared to the negative control. Silver oxynitrate 285 represents a promising compound with in vivo activity for the management of burn wound 286 healing and infection. 287
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